Table 4.
FLI | P-value | |||
---|---|---|---|---|
<30 | Intermediate | ≥60 | ||
Men | ||||
No. DM cases | 13 (6.2%) | 27 (13.5%) | 25 (16.0%) | 0.008† |
No. patients with HbA1c > 6.4 | 13 (6.2%) | 26 (13.0%) | 21 (13.5%) | |
No. patients taking treatments for DM | 0 (0.0%) | 4 (2.0%) | 8 (5.1%) | |
Unadjusted odds ratio | Reference | 2.35 [1.18–4.70] | 2.88 [1.42–5.83] | 0.003 |
Adjusted odds ratio | Reference | 2.28 [1.12–4.63] | 2.68 [1.29–5.56] | 0.023 |
Women | ||||
No. DM patients | 9 (0.3%) | 7 (8.6%) | 8 (25.8%) | <0.001† |
No. patients with HbA1c >6.4 | 6 (0.2%) | 7 (8.6%) | 7 (22.6%) | |
No. patients taking treatments for DM | 3 (0.1%) | 1 (1.2%) | 1 (3.2%) | |
Unadjusted odds ratio | Reference | 2.95 [1.07–8.19] | 10.86 [3.83–30.82] | <0.001 |
Adjusted odds ratio | Reference | 3.01 [1.03–8.78] | 10.35 [3.22–33.31] | <0.001 |
Compared using the χ2-test. Other comparisons made using the trend test.
Hosmer–Lemeshow goodness of fit: P = 0.714 in men, and P = 0.651 in women, respectively.
Adjusted by age, smoking habits, physical activities, eating habits before sleeping,eating fast, hypertension, hypercholesterolemia and prefecture.
DM, diabetes mellitu; FLI, fatty liver index.